IL6 and COVID-19: Since IL-6 levels have consistently been identified as a strong prognostic indicator of severe disease in hospitalised COVID-19 patients21, this study explored correlations between common routine biomarkers of patients from two distinct settings characteristic of disease severity [general wards and CCU], focusing on TF tests.